New Drug for Advanced Kidney Cancer

by Dr. Trupti Shirole on  December 24, 2010 at 10:40 PM Drug News   - G J E 4
Advanced kidney cancer can now be treated with a new drug called Votrient (pazopanib), recommends National Institute for Health and Clinical Excellence (Nice), provided the patients meet certain criteria, including no previous cytokine therapy.
 New Drug for Advanced Kidney Cancer
New Drug for Advanced Kidney Cancer

Pharmaceutical company GlaxoSmithKline (GSK) has agreed to offer 12.5% discount on the list price to the NHS. A clinical trial is being conducted to compare pazopanib to sunitinib (Sutent), which is already approved. GSK has guaranteed a financial rebate if Votrient proves to be inferior to Sutent in the clinical trial. Director of health technology evaluation centre at Nice, Dr Carole Longson, said, "Sunitinib is recommended by Nice for first-line treatment of advanced renal cell carcinoma. Pazopanib will offer patients an additional option and, for some, a more favourable side effect profile."

More than 8,000 new cases of kidney cancer are diagnosed per year in the UK. About half of these cases will lead to death. Almost 4 of 10 patients are diagnosed only when their cancer reaches an advanced stage.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
When are we going to hear about cancer cures - not from the drug companies that's for sure. The are a number of interesting claims from the USA but whether these are "snake oil salesman" pitches I do not know - can't someone in UK check them out
grandparr Friday, December 24, 2010

You May Also Like